Treatment of Heart Disease with an Intraventricular Sac
Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R44HL078071-01
Agency Tracking Number: HL078071
Amount: $94,624.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solitcitation Year: 2004
Solitcitation Topic Code: N/A
Solitcitation Number: PHS2004-2
Small Business Information
MC3, INC.
MC3, INC., 3550 W LIBERTY RD, STE 3, ANN ARBOR, MI, 48103
Duns: N/A
Hubzone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
Name: SEAN Chambers
Phone: (734) 995-9089
Email: schambers@mc3corp.com
Phone: (734) 995-9089
Email: schambers@mc3corp.com
Business Contact
Name: SCOTT MERZ
Phone: (734) 995-9089
Email: MERZ@MC3CORP.COM
Phone: (734) 995-9089
Email: MERZ@MC3CORP.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The purpose of this project is to develop a diastolic volume limiting apparatus (divola) for treatment of advanced heart disease in humans. This technology is an entirely new method of treatment of heart disease, and m * information listed above is at the time of submission.
